700 related articles for article (PubMed ID: 19464043)
1. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
3. Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis.
Oh MM; Chae JY; Kim JW; Kim JW; Yoon CY; Park MG; Moon du G
Urology; 2013 Jun; 81(6):1209-12. PubMed ID: 23601450
[TBL] [Abstract][Full Text] [Related]
4. Editorial comment.
Bamberger MH
Urology; 2009 Jul; 74(1):123-4. PubMed ID: 19567295
[No Abstract] [Full Text] [Related]
5. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Ena J; Arjona F; Martínez-Peinado C; López-Perezagua Mdel M; Amador C
Urology; 2006 Dec; 68(6):1169-74. PubMed ID: 17169640
[TBL] [Abstract][Full Text] [Related]
7. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
[TBL] [Abstract][Full Text] [Related]
8. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
Young JL; Liss MA; Szabo RJ
Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
[TBL] [Abstract][Full Text] [Related]
9. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.
Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H
Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran.
Mehrgan H; Rahbar M
Int J Antimicrob Agents; 2008 Feb; 31(2):147-51. PubMed ID: 18060745
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria.
Suankratay C; Jutivorakool K; Jirajariyavej S
J Med Assoc Thai; 2008 Aug; 91(8):1172-81. PubMed ID: 18788687
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
Akyar I
Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
[TBL] [Abstract][Full Text] [Related]
18. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in pediatric patients in China].
Wang L; Yang YH; Lu Q; Wang Y; Chen Y; Deng L; Deng QL; Zhang H; Wang CQ; Liu L; Xu XW; Shen XZ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1372-5. PubMed ID: 18953872
[TBL] [Abstract][Full Text] [Related]
20. [Incidence of infections dues to Escherichia coli strains producing extended spectrum betalactamase, in the Zou/Collines Hospital Centre (CHDZ/C) in Benin].
Ahoyo AT; Baba-Moussa L; Anago AE; Avogbe P; Missihoun TD; Loko F; Prévost G; Sanni A; Dramane K
Med Mal Infect; 2007 Nov; 37(11):746-52. PubMed ID: 17434702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
